Vigilância laboratorial de paralisia flácida aguda em um país sem pólio/Acute flaccid paralysis laboratorial surveillance in a polio-free country: Brazil, 2005-2014

Sousa Júnior, Ivanildo P. de; Burlandy, Fernanda M; Oliveira, Silas S; Nunes, Amanda M; Sousa, Cristiane; Silva, Elaine M. da; Souza, Jaqueline G. A; Paula, Valdemar A. de; Oliveira, Ivone C. M; Neto Tavares, Fernando; Costa, Eliane V. da; Silva, Edson Elias da.
Hum Vaccin Immunother ; 13(3): 717-723, 2017. graf, tab
Artigo em Inglês | Instituto Evandro Chagas (SOPHIA) | ID: iec-16138

Documentos relacionados

  1. Polio eradication: Addressing the hurdles on the last mile.
  2. Time Taken to Detect and Respond to Polio Outbreaks in Africa and the Potential Impact of Direct Molecular Detection and Nanopore Sequencing.
  3. Sabin polio virus protein 1 (VP1) evolution in patients with acute flaccid paralysis from 2010 to 2016 in Uganda.
  4. Evaluation of the Acute flaccid paralysis surveillance indicators in Zambia from 2015-2021: a retrospective analysis.
  5. An imported case of vaccine-derived poliovirus type 2, Spain in the context of the ongoing polio Public Health Emergency of International Concern, September 2021.
  6. Environmental surveillance detects circulating vaccine-derived poliovirus type 2 that was undetected by acute flaccid paralysis surveillance in 2021 in Uganda.
  7. Poliovirus returns to the UK after nearly 40 years: current efforts and future recommendations.
  8. Coordinated Response to Imported Vaccine-Derived Poliovirus Infection, Barcelona, Spain, 2019-2020.
  9. Evaluation of acute flaccid paralysis surveillance indicators in Sokoto state, Nigeria, 2012-2019: a secondary data analysis.
  10. Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3.